In 2016, the Yale Psychedelic Science Group was established as a forum where clinicians and scholars from across Yale can learn about and discuss the rapidly re-emerging field of psychedelic science and therapeutics in an academically rigorous manner.
Additionally, Yale School Medicine has been home to Ceruvia Lifesciences’ research into utilizing psychedelics to treat Cluster Headache, Migraines, and OCD since 2015.
Activities
Research Institute
Topics of Interest
Obsessive-Compulsive Disorder
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Related Course(s)
Johns Hopkins, Yale & NYU Psychedelic Therapist Training ProgramJohns Hopkins University, Yale University, and New York University are teaming up to develop a curriculum for psychiatrists on psychedelics, with a $1 million grant funding the project over 2 years.